EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 60 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,021,000 | -22.3% | 252,972 | -15.3% | 0.00% | -20.0% |
| Q2 2023 | $2,600,000 | +196.1% | 298,804 | 0.0% | 0.01% | +150.0% |
| Q1 2023 | $878,000 | -16.1% | 298,804 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,046,000 | -55.8% | 298,804 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $2,364,000 | +0.5% | 298,804 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $2,352,000 | -35.2% | 298,804 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $3,630,000 | -0.7% | 298,804 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,657,000 | -33.6% | 298,804 | -43.5% | 0.01% | -46.7% |
| Q3 2021 | $5,506,000 | +15.9% | 528,428 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $4,750,000 | -11.5% | 528,428 | -0.0% | 0.01% | -17.6% |
| Q1 2021 | $5,369,000 | +54.4% | 528,468 | 0.0% | 0.02% | +21.4% |
| Q4 2020 | $3,477,000 | – | 528,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |